CpG DNA: A pathogenic factor in systemic lupus erythematosus? View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1995-11

AUTHORS

Arthur M. Krieg

ABSTRACT

Systemic lupus erythematosus (SLE) is a multifactorial disease of unknown etiology. Characteristic features of SLE include (1) polyclonal B cell activation, (2) overexpression of the immune stimulatory cytokine interleukin-6 (IL-6), (3) defective tolerance to self antigens, and (4) production of anti-DNA antibodies (Ab). Bacterial infection has been suspected as a triggering factor for lupus. Bacterial DNA differs from vertebrate DNA in the frequency and methylation of CpG dinucleotides. These CpG motifs in bacterial DNA induce a variety of immune effects, including (1) polyclonal activation of murine and human B cells, (2) IL-6 secretion, and (3) resistance to apoptosis, thereby potentially allowing the survival of autoreactive cells. These results suggest that microbial DNA could therefore be a pathogenic factor in SLE. SLE patients have elevated levels of circulating plasma DNA which is reportedly enriched in hypomethylated CpGs. Genomic DNA is also hypomethylated in SLE. The purpose of this review is to summarize the immune effects of CpG motifs and to present the evidence for their possible involvement in the pathogenesis of SLE. More... »

PAGES

284-292

Journal

TITLE

Journal of Clinical Immunology

ISSUE

6

VOLUME

15

Related Patents

  • Immunostimulatory Oligonucleotides And Uses Thereof
  • For Treatment Of Atopic Conditions (Dermatitis, Allergies) And Influenza Virus; Point Mutations
  • Sequences With Unmethylated Cpg (Cytosine-Guanine) Dinucleotides That Modulate An Immune Response Including Stimulating A Th1 Pattern Of Immune Activation, Cytokine Production, Nk Lytic Activity, And B Cell Proliferation, Also
  • Immunostimulatory Nucleic Acid Molecules
  • Methods Of Using Immunostimulatory Nucleic Acid Molecules To Treat Allergic Conditions
  • Immunostimulatory Oligonucleotides And Uses Thereof
  • Administering Nucleic Acid To Activate Surface Antigen; Anticancer Agents
  • Oligonucleotides Having A '5tcg Motif Without Any Additional Unmethylated Cpg Motifs Have Strong Immunostimulatory Capability
  • Immunostimulatory Nucleic Acid Molecules
  • For Extending Clinical Utility Of Ifn-Alpha In Treatment Of A Variety Of Viral And Proliferative Disorders; Invention Provides Methods Which Increase Efficacy Of Ifn- Alpha And Reduce Ifn- Alpha Treatment-Related Side Effects
  • Immunostimulatory Nucleic Acid Molecules
  • Immunostimulatory Nucleic Acid Molecules
  • Immunostimulatory Nucleic Acid Molecules
  • Of Given Nucleotide Sequence; Encapsulated In Slow Release Delivery Vehicle; Includes Viral Or Bacterial Antigen; Increases Cell Proliferation, Differentiation, Cytokine And Antibody Production For Lymphocytes
  • Using Oligonucleotide/Delivery Complexes To Enhance Immune Response Via Increase Interferon Concentration; Antisense Therapies; Gene Expression Inhibition; Viricides
  • Immunostimulatory Nucleic Acid Molecules
  • Administering Immunopotentiating Cytokine Selected From Group Consisting Of Gm-Csf, Il-2, Il-4 And Ifn-.Gamma., And Immunostimulatory Cpg Oligonucleotide For Inducing Synergistic Antigen Specific Immune Response
  • Demethylated And/Or Oxidized Membrane Dna
  • Immunostimulatory Nucleic Acid Molecules
  • Contacting Dendritic Cell With An Isolated Nucleic Acid Containing At Least One Unmethylated Cpg Dinucleotide Wherein The Nucleic Acid Is From 8-80 Bases In Length In An Amount Effective To Activate Dendritic Cell
  • Immunostimulatory Nucleic Acid Molecules
  • Combination Motif Immune Stimulatory Oligonucleotides With Improved Activity
  • Immunostimulatory Polynucleotide/Immunomodulatory Molecule Conjugates
  • Method Of Treating Cancer Using Immunostimulatory Oligonucleotides
  • Vectors And Methods For Immunization Or Therapeutic Protocols
  • For Extending Clinical Utility Of Interferon (Ifn) Alpha In Treatment Of A Variety Of Viral And Proliferative Disorders; Increase Efficacy Of Ifn- Alpha And Reduce Ifn- Alpha Treatment-Related Side Effects
  • Oligodeoxynucleotide And Its Use To Induce An Immune Response
  • Olioodeoxynucleotide And Its Use To Induce An Immune Response
  • Use Of Nucleic Acids Containing Unmethylated Cpc Dinucleotide In The Treatment Of Lps-Associated Disorders
  • Immunomodulatory Oligonucleotides
  • Modified Polynucleotides Have At Least One Phosphorothioate Linkage; Animal Growth Regulators; Immunomodulation, Immunotherapy; Nontoxic
  • Use Of Nucleic Acids Containing Unmethylated Cpg Dinucleotide As An Adjuvant
  • Containing Unmethylated Cpg Dinucleotides; Redirection Of A Th2 Response To A Th1 Response; Atopic Diseases, Dermatitis
  • Immunostimulatory Nucleic Acid Molecules
  • Multiple Cpg Oligodeoxynucleotide And Their Use To Induce An Immune Response
  • Immune Stimulation By Phosphorothioate Oligonucleotide Analogs
  • Ameliorating An Immune System Deficiency In A Subject, Comprising The Steps Of Contacting Lymphocytes Obtained From The Subject With An Antigen And An Immunostimulatory Nucleic Acid
  • For Treatment Of Atopic Conditions (Dermatitis, Allergies); Point Mutations; Immunotherapy
  • Treating Asthma, Immunostimulatory Polynucleotide Comprising An Immunostimulatory Sequence (Iss), Wherein The Iss Comprises The Sequence 5'-Cytosine-Guanine-3'
  • Immunomodulatory Oligonucleotides
  • Nucleic Acid Compositions For Stimulating Immune Responses
  • Vectors And Methods For Immunization Or Therapeutic Protocols
  • Nucleic Acid Compositions For Stimulating Immune Responses
  • Immunostimulatory; Modulating Immune Response
  • Nucleic Acids Containing Unmethylated Cytosine-Guanine Dinucleotides Activate Lymphocytes And Redirect An Immune Response From Th2 To Th1
  • Methods And Products For Inducing Mucosal Immunity
  • Modulate Immunology Response; Asthma Therapy; Autoimmune Disease
  • Immunostimulatory Polynucleotide/Immunomodulatory Molecule Conjugates
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/bf01541318

    DOI

    http://dx.doi.org/10.1007/bf01541318

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1040661332

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/8576314


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Immunology", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Base Sequence", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "DNA, Bacterial", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Dinucleoside Phosphates", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Lupus Erythematosus, Systemic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Molecular Sequence Data", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Veterans Affairs, 52246, Iowa City, Iowa", 
              "id": "http://www.grid.ac/institutes/grid.410347.5", 
              "name": [
                "Department of Internal Medicine, University of Iowa College of Medicine, 52242, Iowa City, Iowa", 
                "Department of Veterans Affairs, 52246, Iowa City, Iowa"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Krieg", 
            "givenName": "Arthur M.", 
            "id": "sg:person.0703121154.11", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0703121154.11"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/364645a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000725210", 
              "https://doi.org/10.1038/364645a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/374546a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1034049921", 
              "https://doi.org/10.1038/374546a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/321209a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022096390", 
              "https://doi.org/10.1038/321209a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/349331a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038119612", 
              "https://doi.org/10.1038/349331a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf01477498", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010974195", 
              "https://doi.org/10.1007/bf01477498"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00003088-199528010-00002", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047632676", 
              "https://doi.org/10.2165/00003088-199528010-00002"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/373252a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013174466", 
              "https://doi.org/10.1038/373252a0"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1995-11", 
        "datePublishedReg": "1995-11-01", 
        "description": "Systemic lupus erythematosus (SLE) is a multifactorial disease of unknown etiology. Characteristic features of SLE include (1) polyclonal B cell activation, (2) overexpression of the immune stimulatory cytokine interleukin-6 (IL-6), (3) defective tolerance to self antigens, and (4) production of anti-DNA antibodies (Ab). Bacterial infection has been suspected as a triggering factor for lupus. Bacterial DNA differs from vertebrate DNA in the frequency and methylation of CpG dinucleotides. These CpG motifs in bacterial DNA induce a variety of immune effects, including (1) polyclonal activation of murine and human B cells, (2) IL-6 secretion, and (3) resistance to apoptosis, thereby potentially allowing the survival of autoreactive cells. These results suggest that microbial DNA could therefore be a pathogenic factor in SLE. SLE patients have elevated levels of circulating plasma DNA which is reportedly enriched in hypomethylated CpGs. Genomic DNA is also hypomethylated in SLE. The purpose of this review is to summarize the immune effects of CpG motifs and to present the evidence for their possible involvement in the pathogenesis of SLE.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/bf01541318", 
        "isAccessibleForFree": false, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.2625742", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1092207", 
            "issn": [
              "0271-9142", 
              "1573-2592"
            ], 
            "name": "Journal of Clinical Immunology", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "6", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "15"
          }
        ], 
        "keywords": [
          "systemic lupus erythematosus", 
          "methylation of CpG", 
          "lupus erythematosus", 
          "immune effects", 
          "pathogenic factors", 
          "bacterial DNA", 
          "CpG motifs", 
          "pathogenesis of SLE", 
          "polyclonal B cell activation", 
          "vertebrate DNA", 
          "microbial DNA", 
          "IL-6 secretion", 
          "genomic DNA", 
          "cytokine interleukin-6", 
          "anti-DNA antibodies", 
          "B cell activation", 
          "human B cells", 
          "DNA", 
          "SLE patients", 
          "autoreactive cells", 
          "unknown etiology", 
          "self antigens", 
          "interleukin-6", 
          "polyclonal activation", 
          "defective tolerance", 
          "B cells", 
          "multifactorial disease", 
          "cell activation", 
          "bacterial infections", 
          "plasma DNA", 
          "motif", 
          "elevated levels", 
          "possible involvement", 
          "erythematosus", 
          "CpG", 
          "cells", 
          "activation", 
          "methylation", 
          "overexpression", 
          "apoptosis", 
          "lupus", 
          "patients", 
          "murine", 
          "pathogenesis", 
          "etiology", 
          "infection", 
          "factors", 
          "antigen", 
          "disease", 
          "secretion", 
          "antibodies", 
          "survival", 
          "tolerance", 
          "involvement", 
          "characteristic features", 
          "effect", 
          "review", 
          "production", 
          "evidence", 
          "levels", 
          "resistance", 
          "variety", 
          "frequency", 
          "purpose", 
          "features", 
          "results"
        ], 
        "name": "CpG DNA: A pathogenic factor in systemic lupus erythematosus?", 
        "pagination": "284-292", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1040661332"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/bf01541318"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "8576314"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/bf01541318", 
          "https://app.dimensions.ai/details/publication/pub.1040661332"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-12-01T06:21", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_303.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/bf01541318"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf01541318'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf01541318'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf01541318'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf01541318'


     

    This table displays all metadata directly associated to this object as RDF triples.

    182 TRIPLES      21 PREDICATES      105 URIs      90 LITERALS      13 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/bf01541318 schema:about N044038001fe54e39b737289ceb374181
    2 N2b12458bc84447dfbb80dd10d99e417a
    3 N560a9e8daf9d4b3aa9301e2d30e06112
    4 N69251c75bf4c45a8a6bda8b6d428ae1b
    5 N8d159a668d2440c0b945beede2f4154c
    6 Nd2e94e245a684963846a9d8f19c2be71
    7 anzsrc-for:11
    8 anzsrc-for:1107
    9 schema:author N46dfa5042f684829b9154e5a061c9050
    10 schema:citation sg:pub.10.1007/bf01477498
    11 sg:pub.10.1038/321209a0
    12 sg:pub.10.1038/349331a0
    13 sg:pub.10.1038/364645a0
    14 sg:pub.10.1038/373252a0
    15 sg:pub.10.1038/374546a0
    16 sg:pub.10.2165/00003088-199528010-00002
    17 schema:datePublished 1995-11
    18 schema:datePublishedReg 1995-11-01
    19 schema:description Systemic lupus erythematosus (SLE) is a multifactorial disease of unknown etiology. Characteristic features of SLE include (1) polyclonal B cell activation, (2) overexpression of the immune stimulatory cytokine interleukin-6 (IL-6), (3) defective tolerance to self antigens, and (4) production of anti-DNA antibodies (Ab). Bacterial infection has been suspected as a triggering factor for lupus. Bacterial DNA differs from vertebrate DNA in the frequency and methylation of CpG dinucleotides. These CpG motifs in bacterial DNA induce a variety of immune effects, including (1) polyclonal activation of murine and human B cells, (2) IL-6 secretion, and (3) resistance to apoptosis, thereby potentially allowing the survival of autoreactive cells. These results suggest that microbial DNA could therefore be a pathogenic factor in SLE. SLE patients have elevated levels of circulating plasma DNA which is reportedly enriched in hypomethylated CpGs. Genomic DNA is also hypomethylated in SLE. The purpose of this review is to summarize the immune effects of CpG motifs and to present the evidence for their possible involvement in the pathogenesis of SLE.
    20 schema:genre article
    21 schema:isAccessibleForFree false
    22 schema:isPartOf Nbf5ee9b1dd3745eebaf6e3cffaea762f
    23 Nea418b050f114e36aa5dd45532d961b5
    24 sg:journal.1092207
    25 schema:keywords B cell activation
    26 B cells
    27 CpG
    28 CpG motifs
    29 DNA
    30 IL-6 secretion
    31 SLE patients
    32 activation
    33 anti-DNA antibodies
    34 antibodies
    35 antigen
    36 apoptosis
    37 autoreactive cells
    38 bacterial DNA
    39 bacterial infections
    40 cell activation
    41 cells
    42 characteristic features
    43 cytokine interleukin-6
    44 defective tolerance
    45 disease
    46 effect
    47 elevated levels
    48 erythematosus
    49 etiology
    50 evidence
    51 factors
    52 features
    53 frequency
    54 genomic DNA
    55 human B cells
    56 immune effects
    57 infection
    58 interleukin-6
    59 involvement
    60 levels
    61 lupus
    62 lupus erythematosus
    63 methylation
    64 methylation of CpG
    65 microbial DNA
    66 motif
    67 multifactorial disease
    68 murine
    69 overexpression
    70 pathogenesis
    71 pathogenesis of SLE
    72 pathogenic factors
    73 patients
    74 plasma DNA
    75 polyclonal B cell activation
    76 polyclonal activation
    77 possible involvement
    78 production
    79 purpose
    80 resistance
    81 results
    82 review
    83 secretion
    84 self antigens
    85 survival
    86 systemic lupus erythematosus
    87 tolerance
    88 unknown etiology
    89 variety
    90 vertebrate DNA
    91 schema:name CpG DNA: A pathogenic factor in systemic lupus erythematosus?
    92 schema:pagination 284-292
    93 schema:productId N1e69e5bbb0c14d298ad395a38b888352
    94 N447252c14323476da303cd47622538db
    95 N9f8c9b5d8fac402593c78d24de796ae1
    96 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040661332
    97 https://doi.org/10.1007/bf01541318
    98 schema:sdDatePublished 2022-12-01T06:21
    99 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    100 schema:sdPublisher N8990adf239ab43bdbb31386464e496a8
    101 schema:url https://doi.org/10.1007/bf01541318
    102 sgo:license sg:explorer/license/
    103 sgo:sdDataset articles
    104 rdf:type schema:ScholarlyArticle
    105 N044038001fe54e39b737289ceb374181 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    106 schema:name Lupus Erythematosus, Systemic
    107 rdf:type schema:DefinedTerm
    108 N1e69e5bbb0c14d298ad395a38b888352 schema:name dimensions_id
    109 schema:value pub.1040661332
    110 rdf:type schema:PropertyValue
    111 N2b12458bc84447dfbb80dd10d99e417a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    112 schema:name DNA, Bacterial
    113 rdf:type schema:DefinedTerm
    114 N447252c14323476da303cd47622538db schema:name pubmed_id
    115 schema:value 8576314
    116 rdf:type schema:PropertyValue
    117 N46dfa5042f684829b9154e5a061c9050 rdf:first sg:person.0703121154.11
    118 rdf:rest rdf:nil
    119 N560a9e8daf9d4b3aa9301e2d30e06112 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    120 schema:name Base Sequence
    121 rdf:type schema:DefinedTerm
    122 N69251c75bf4c45a8a6bda8b6d428ae1b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    123 schema:name Humans
    124 rdf:type schema:DefinedTerm
    125 N8990adf239ab43bdbb31386464e496a8 schema:name Springer Nature - SN SciGraph project
    126 rdf:type schema:Organization
    127 N8d159a668d2440c0b945beede2f4154c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    128 schema:name Dinucleoside Phosphates
    129 rdf:type schema:DefinedTerm
    130 N9f8c9b5d8fac402593c78d24de796ae1 schema:name doi
    131 schema:value 10.1007/bf01541318
    132 rdf:type schema:PropertyValue
    133 Nbf5ee9b1dd3745eebaf6e3cffaea762f schema:volumeNumber 15
    134 rdf:type schema:PublicationVolume
    135 Nd2e94e245a684963846a9d8f19c2be71 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    136 schema:name Molecular Sequence Data
    137 rdf:type schema:DefinedTerm
    138 Nea418b050f114e36aa5dd45532d961b5 schema:issueNumber 6
    139 rdf:type schema:PublicationIssue
    140 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    141 schema:name Medical and Health Sciences
    142 rdf:type schema:DefinedTerm
    143 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
    144 schema:name Immunology
    145 rdf:type schema:DefinedTerm
    146 sg:grant.2625742 http://pending.schema.org/fundedItem sg:pub.10.1007/bf01541318
    147 rdf:type schema:MonetaryGrant
    148 sg:journal.1092207 schema:issn 0271-9142
    149 1573-2592
    150 schema:name Journal of Clinical Immunology
    151 schema:publisher Springer Nature
    152 rdf:type schema:Periodical
    153 sg:person.0703121154.11 schema:affiliation grid-institutes:grid.410347.5
    154 schema:familyName Krieg
    155 schema:givenName Arthur M.
    156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0703121154.11
    157 rdf:type schema:Person
    158 sg:pub.10.1007/bf01477498 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010974195
    159 https://doi.org/10.1007/bf01477498
    160 rdf:type schema:CreativeWork
    161 sg:pub.10.1038/321209a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022096390
    162 https://doi.org/10.1038/321209a0
    163 rdf:type schema:CreativeWork
    164 sg:pub.10.1038/349331a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038119612
    165 https://doi.org/10.1038/349331a0
    166 rdf:type schema:CreativeWork
    167 sg:pub.10.1038/364645a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000725210
    168 https://doi.org/10.1038/364645a0
    169 rdf:type schema:CreativeWork
    170 sg:pub.10.1038/373252a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013174466
    171 https://doi.org/10.1038/373252a0
    172 rdf:type schema:CreativeWork
    173 sg:pub.10.1038/374546a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034049921
    174 https://doi.org/10.1038/374546a0
    175 rdf:type schema:CreativeWork
    176 sg:pub.10.2165/00003088-199528010-00002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047632676
    177 https://doi.org/10.2165/00003088-199528010-00002
    178 rdf:type schema:CreativeWork
    179 grid-institutes:grid.410347.5 schema:alternateName Department of Veterans Affairs, 52246, Iowa City, Iowa
    180 schema:name Department of Internal Medicine, University of Iowa College of Medicine, 52242, Iowa City, Iowa
    181 Department of Veterans Affairs, 52246, Iowa City, Iowa
    182 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...